Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.

NCT03175952 is registered in ClinicalTrials.gov with Tianjin Chest Hospital as lead sponsor.

NCT NCT03175952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03175952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.
Lead sponsor
Tianjin Chest Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2017
Completion date
May 1, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major adverse cardiovascular events, percutaneous coronary intervention, saphenous vein graft disease, virtual histology intravascular ultrasound